This is the authors' abstract. We don't add key points for this paper.
The yeast mating pathway regulates haploid cell fusion in response to pheromone signaling via a mitogen-activated protein kinase (MAPK) cascade that controls directional growth (chemotropism). However, the regulators of chemotropic morphogenesis are ill-defined. By using a non-biased genome-wide screen, we identified hundreds of genes that affect mating. An additional screens identified and validated >20 novel positive and negative regulators of pheromone gradient sensing, chemotropism, shmoo development, and mating. Aside from known regulators of exocytosis and endocytosis, genes involved in translational control downstream of the G-protein-regulated pheromone and filamentous growth MAPK pathways were identified. These include the Scp160 RNA-binding protein and the Asc1, Rpl12b, and Rpl19b ribosomal proteins (RPs). Importantly, we demonstrate that pheromone treatment and G α (Gpa1) activation stimulate Scp160 binding to (and inhibition of) Asc1, which acts downstream of glucose-activated G α (Gpa2) on the filamentous growth pathway. Moreover, we identify both Rpl12b and Rpl19b as RP paralog-specific positive regulators of translation of mating components, including Scp160. Thus, opposing MAPK pathways may converge at the level of translational control to regulate signaling output.
No takes yet. Share an insight, caveat, or question.
Gelin-Licht et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: